bupranolol has been researched along with Asthma in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murai, T | 1 |
| Maejima, T | 1 |
| Sanai, K | 1 |
| Osada, E | 1 |
1 other study available for bupranolol and Asthma
| Article | Year |
|---|---|
Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
Topics: Acetylcholine; Adrenergic beta-Agonists; Airway Resistance; Animals; Asthma; Blood Gas Analysis; Blo | 1984 |